Triskelion’s experts Yuzhu (Celia) Wei and Ingrid Sterenborg discuss the present practice of assessing endocrine disrupting properties of co-formulants and suggest possible improvements.

There’s increasing regulatory focus on endocrine disruptors (EDs). In 2018, the EU agreed on scientific criteria for the evaluation of EDs for the Plant Protection Products Regulation (PPPR) and the Biocidal Products Regulation (BPR). Information requirements for EDs are also being developed for Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and a draft proposal is expected in 2022.

Most of the regulators’ and scientists’ attention has been on active substances in biocidal or plant protection products. But how can non-active substances used in these products be evaluated?

To read on, download the full article published by Chemical Watch below.

Please follow this link to the article: click here.

Interested to know how we can support your case?
Feel free to contact Isabel van Laanen (for Biocides and Plant Protection Products)tel: +31 6 5000 7475 or  Paul Stoffels (for REACH) tel: +31 6 5280 3578